Work

Co-treatment with vorinostat and Aurora kinase inhibitor MK-0457 exerts synergistic antileukemia activity against AML and CML cells, including those expressing mutant Bcr-AblT315I

Year: 2008

Type: article

Source: Cancer Research

Authors: Warren Fiskus, Yongchao Wang, Rajeshree Joshi, Rekha Rao, Pearl Lee, Yonghua Yang, Kelly Eaton, Jianguang Chen, Ravindra Kolhe, Pravina Fernandez, Anand Jillella, Carolyn A. Buser, Kapil N. Bhalla

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2788907867

FWCI:

Cites:

Cited by:

Related to: 10